Evaluation of the Effectiveness of the Abatacept (Orencia®) IV and SC Patient Alert Cards in Patients With Rheumatoid Arthritis in European Economic Area Countries
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 14 Jun 2017 Status changed from recruiting to completed.
- 13 Apr 2017 Planned End Date changed from 1 Dec 2016 to 29 Sep 2017.
- 13 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 29 Sep 2017.